Polycystic Kidney Disease — Outline

What is Polycystic Kidney Disease?

A hereditary disorder characterized by the progressive growth of fluid-filled cysts in both kidneys, leading to kidney enlargement and eventual loss of renal function. It is the 4th leading cause of End-Stage Renal Disease worldwide.

Types

ADPKD Most Common

Autosomal Dominant PKD

🧬 Genes: PKD1 (chr 16, ~85%) · PKD2 (chr 4, ~15%)
📅 Onset: Adults 30–50 yrs (symptoms delayed)
🔁 Inheritance: 50% chance per child
🏥 ESRD: ~50% by age 60
🫀 Extrarenal: Hepatic cysts, intracranial aneurysms, MVP

ARPKD Rare

Autosomal Recessive PKD

🧬 Gene: PKHD1 (chr 6)
📅 Onset: Perinatal / childhood
🔁 Inheritance: 25% chance per child (both parents carriers)
🏥 ESRD: Often within first decade of life
🫀 Extrarenal: Congenital hepatic fibrosis, portal hypertension

Pathophysiology

Disease Progression

Gene Mutation (PKD1 / PKD2 / PKHD1)

Defective polycystin proteins disrupt calcium signaling in renal tubular epithelium
↑ cAMP Signaling + mTOR Pathway Activation

Drives abnormal tubular cell proliferation and fluid secretion into cysts
Cyst Formation & Expansion

Cysts detach from tubules; grow independently, compressing surrounding parenchyma
Nephron Loss + Fibrosis

Progressive destruction of functional renal tissue; GFR declines
End-Stage Renal Disease

Dialysis or transplantation required

Clinical Manifestations

System	Finding	Notes
Renal	Flank / abdominal pain	Most common presenting symptom — cyst enlargement, hemorrhage, or stone
Renal	Hematuria	Gross or microscopic; cyst rupture into collecting system
Renal	Nephrolithiasis	Uric acid & calcium oxalate stones; ~20% of patients
Renal	Recurrent UTIs / Cyst Infections	Women > Men; E. coli most common organism
Cardiovascular	Hypertension	Earliest manifestation; RAAS activation from cyst compression of vasculature
Cardiovascular	Mitral Valve Prolapse	~25% of ADPKD patients; usually benign
Neurological	Intracranial Aneurysm	8–12% prevalence; rupture → subarachnoid hemorrhage (SAH)
Hepatic	Hepatic Cysts	Most common extrarenal manifestation; liver function usually preserved

Critical Complication — Intracranial Aneurysm Rupture

Sudden severe ("thunderclap") headache in a PKD patient is a neurological emergency. Assess for neck stiffness, photophobia, altered LOC. Anticipate stat CT head and neurosurgical consult.

Key Statistics

Prevalence (ADPKD)

1 in 400–1,000

Most common inherited kidney disease

ESRD Risk by Age 60

~50%

PKD1 mutations carry higher risk than PKD2

Intracranial Aneurysm

8–12%

Screen if family Hx of aneurysm / SAH

Hepatic Cysts

~80%

By age 60 in ADPKD; liver function preserved

Diagnosis & Management

🔬 Diagnostic Criteria (Pei Unified Criteria for ADPKD)

Age 15–39: ≥3 total cysts (unilateral or bilateral) on ultrasound
Age 40–59: ≥2 cysts in each kidney
Age ≥60: ≥4 cysts in each kidney
First-line imaging: Renal ultrasound (non-invasive, no radiation)
Advanced imaging: MRI (total kidney volume — TKV — used to predict progression; Mayo Classification)
Genetic testing: When imaging inconclusive or for living-related donor evaluation

💊 Pharmacologic Management

Drug	Mechanism	Indication / Notes
`Tolvaptan`	Vasopressin V2 receptor antagonist → ↓ cAMP → slows cyst growth	Rapidly progressive ADPKD — hepatotoxicity risk; monitor LFTs
`ACE Inhibitors / ARBs`	RAAS blockade → BP control + renoprotection	First-line for hypertension in PKD
`Statins`	Investigational — may slow TKV growth	Not yet standard of care; studied in pediatric ADPKD

🏥 Non-Pharmacologic & Lifestyle

💧 High water intake (>3 L/day) — suppresses ADH → ↓ cAMP → slows cyst growth
☕ Avoid caffeine — increases intracellular cAMP, promotes cyst growth
🧂 Low-sodium diet — supports BP control
🥗 Protein restriction — once CKD stage 3+ to slow GFR decline
🚫 NSAIDs — avoid; nephrotoxic in CKD
🔄 Renal Replacement Therapy — hemodialysis, peritoneal dialysis, or kidney transplantation at ESRD

Nursing Considerations

Priority Nursing Actions

Monitor

BP, BUN, Serum Creatinine, GFR, I&O — assess renal function trajectory
Assess

Pain character and location — distinguish cyst hemorrhage, stone, or infection
Alert

Sudden severe headache → neurological emergency — intracranial aneurysm rupture until ruled out
Educate

Fluid intake goals, caffeine avoidance, medication adherence, genetic counseling referral for family members

Clinical Reasoning Note

The key "aha" for PKD is that it is a systemic connective tissue disorder, not just a kidney disease. Intracranial aneurysms, MVP, and hepatic cysts are all part of the same defective polycystin protein story. Whenever a patient with known PKD presents with a sudden severe headache, the first thought must be SAH — not just a tension headache. Equally important: hypertension in PKD is RAAS-driven and should be treated aggressively with ACE inhibitors or ARBs long before GFR starts to fall.

"In ADPKD, the rate of kidney growth (total kidney volume) is a better early predictor of progression than GFR — start monitoring TKV before creatinine rises."

Concordance Cross-Reference

Autosomal Dominant PKD Autosomal Recessive PKD cAMP Signaling Chronic Kidney Disease End-Stage Renal Disease Genetic Counseling Hematuria Hepatic Cysts Hypertension Intracranial Aneurysm Kidney Transplantation mTOR Pathway Nephrolithiasis Subarachnoid Hemorrhage Tolvaptan Urinary Tract Infection